⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MAIA News
MAIA Biotechnology, Inc.
Form 8-K
sec.gov
MAIA
MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer
globenewswire.com
MAIA
Form 8-K
sec.gov
MAIA
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
globenewswire.com
MAIA
Form 8-K
sec.gov
MAIA
Form 8-K
sec.gov
MAIA
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
globenewswire.com
MAIA
Form 8-K
sec.gov
MAIA
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
globenewswire.com
MAIA
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
globenewswire.com
MAIA